Neurable funding validates consumer BCI with $35M Series A

Neurable, the Boston-based neurotechnology firm, has secured a $35 million Series A funding round, pushing its total capital raised to $65 million. The investment, led by Spectrum Moonshot Fund, is a major validation for the burgeoning consumer brain-computer interface (BCI) market, signaling that investors are ready to back companies moving neural tracking out of specialized labs and into everyday wearables.

The core of Neurable’s strategy is its patented ‘Neurable AI,’ a compact brain-signal processing technology designed to integrate seamlessly into existing consumer electronics, most notably headphones. The company’s mission is straightforward: to make cognitive health insights, such as mental fatigue, focus levels, and recovery state, as accessible and common as checking a smartwatch for heart rate or sleep quality.

This latest Neurable funding arrives shortly after the launch of the MW75 Neuro LT, a pair of premium headphones equipped with BCI capabilities, alongside a redesigned app that provides real-time cognitive insights. According to the company, these capabilities have been rigorously validated through independent evaluations and peer-reviewed studies, demonstrating high fidelity in detecting subtle changes in cognitive state.

“Our mission is to make understanding your brain as natural and intuitive as checking your steps,” said Dr. Ramses Alcaide, CEO and Co-Founder of Neurable. He noted that the funding will allow the company to scale Neurable AI into new devices and industries, transforming cognitive health into a daily utility.

Investor confidence stems from Neurable’s ability to translate complex scientific breakthroughs into an elegant, functional consumer product. Mauro Guebeli, Investment Manager at Spectrum Value Management, highlighted the team’s achievement in bringing high-quality BCI technology into a desirable consumer form factor, powered by robust signal-processing algorithms.

The Performance Edge in Gaming and Research

While the ultimate goal is mainstream cognitive wellness, Neurable is strategically targeting high-performance sectors where immediate, measurable gains are crucial. Gaming and esports represent one of the most immediate and intuitive applications for Neurable AI.

In competitive gaming, where reaction time and sustained concentration are paramount, integrating brain insights directly into the workflow offers a new frontier in performance optimization. Adam Molnar, Co-Founder and VP of Strategic Partnerships at Neurable, explained that players are constantly pushing their cognitive limits, and BCI integration opens up new possibilities for both player training and game design.

Beyond the consumer market, the new Neurable funding will also bolster the company’s position within the research ecosystem. Neurable recently partnered with iMotions, a leading human behavior research platform, integrating its headsets into the software suite. This collaboration allows researchers and product teams to capture high-quality neural data at scale, accelerating the development of BCI-enabled products across various industries. The company also collaborated with MeSpace to study how adaptive workstations affect cognitive performance, demonstrating the platform’s utility in occupational health and productivity research.

The global BCI market is projected to exceed $52 billion by 2034. Neurable’s momentum, fueled by this significant Series A round, signals a broader industry shift: brain data is rapidly becoming a foundational layer in how people approach work, play, and personal well-being. The challenge now for Neurable is maintaining the ethical and intuitive deployment of this powerful technology as it seeks to lead the transition of brain understanding from niche science to accessible, daily utility.